Skip to content

Clinical trials

Peripheral Arterial Disease trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Not applicable Country / region: United States Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20063
20074
20082
20094
20106
20119
20127
201311
201410
201515
201612
201717
201816
201910
202012
202112
202214
202316
202413
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed129
Recruiting35
Terminated14
Unknown status12
Active, not recruiting11
Withdrawn7
Not yet recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University12
VA Office of Research and Development12
University of Nebraska9
Indiana University6
Medtronic Endovascular6
University of Oklahoma6
Avinger, Inc.5
C. R. Bard5
W.L.Gore & Associates5
Shockwave Medical, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease212
Intermittent Claudication33
Peripheral Vascular Diseases33
Chronic Limb-Threatening Ischemia18
Diabetes Mellitus14
Atherosclerosis11
Diabetic Foot9
Arterial Occlusive Diseases8
Vascular Diseases8
Cardiovascular Diseases7

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.